Report cover image

Thyroid Cancer Diagnostics Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

Publisher Persistence Research & Consultancy Services
Published Jun 04, 2025
Length 187 Pages
SKU # PERR20090614

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for thyroid cancer diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global thyroid cancer diagnostics market from 2025 to 2032.

Key Insights:
  • Thyroid Cancer Diagnostics Market Size (2025E): USD 3.01 Billion
  • Projected Market Value (2032F): USD 4.28 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.10%
Thyroid Cancer Diagnostics Market – Report Scope:

Thyroid cancer diagnostics play a crucial role in the early detection, monitoring, and management of thyroid malignancies. These diagnostics encompass a range of modalities including imaging techniques, biopsy procedures, molecular testing, and blood assays for thyroid function. The market caters to hospitals, diagnostic laboratories, specialty clinics, and research institutions, offering solutions such as ultrasound imaging, fine needle aspiration biopsy (FNAB), and next-generation sequencing (NGS). Market growth is driven by the increasing incidence of thyroid cancer, advancements in diagnostic technologies, and the rising adoption of personalized medicine approaches in oncology.

Market Growth Drivers:

The global thyroid cancer diagnostics market is propelled by several key factors, including the growing prevalence of thyroid cancer, particularly papillary thyroid carcinoma, and increased awareness about the importance of early diagnosis. Improvements in diagnostic accuracy through molecular and genetic testing technologies have enhanced clinicians' ability to detect malignancies at earlier stages. The rising demand for non-invasive and minimally invasive diagnostic procedures, coupled with favorable reimbursement policies in developed regions, further stimulates market expansion. Moreover, government initiatives promoting cancer screening programs and healthcare infrastructure modernization in emerging economies contribute to broader diagnostic accessibility.

Market Restraints:

Despite strong growth prospects, the thyroid cancer diagnostics market faces challenges including high diagnostic costs, limited access to advanced technologies in low-resource settings, and variability in diagnostic interpretation. Additionally, overdiagnosis of indolent tumors due to increased screening may lead to unnecessary interventions and healthcare burden. Regulatory complexities and the need for highly skilled professionals to interpret genetic and molecular test results may also impede market penetration. Addressing these challenges requires standardization of diagnostic protocols, increased affordability, and investment in healthcare capacity building.

Market Opportunities:

The thyroid cancer diagnostics market presents considerable opportunities driven by emerging diagnostic innovations and the growing emphasis on precision oncology. Integration of artificial intelligence (AI) and machine learning in diagnostic imaging and pathology improves diagnostic efficiency and accuracy. Expansion of liquid biopsy and biomarker-based tests offers non-invasive alternatives with potential for early detection and real-time monitoring. Collaborations between research institutions, biotech firms, and healthcare providers are crucial for developing cost-effective solutions and expanding the reach of advanced diagnostics to underdiagnosed regions. Continued R&D investment and strategic partnerships will play a pivotal role in shaping the future landscape of thyroid cancer diagnostics.

Key Questions Answered in the Report:
  • What are the primary factors driving the growth of the thyroid cancer diagnostics market globally?
  • Which diagnostic methods and technologies are gaining the most traction across healthcare facilities?
  • How are innovations in molecular diagnostics and imaging reshaping the thyroid cancer diagnostic landscape?
  • Who are the key players contributing to the thyroid cancer diagnostics market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global thyroid cancer diagnostics market?
Competitive Intelligence and Business Strategy:

These companies are investing heavily in R&D to develop highly sensitive and specific diagnostic assays, leveraging AI for image interpretation and exploring molecular and genomic biomarkers for targeted diagnosis. Partnerships with healthcare systems and diagnostic laboratories enable broader distribution and enhance test accessibility. In addition, efforts toward regulatory approvals and clinical validation underscore a strong commitment to product credibility and market expansion.

Key Companies Profiled:
  • F.Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories, Inc.
  • GE HealthCare
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Toshiba Corporation
  • Agilent Technologies, Inc.
  • Illumina, Inc.
Thyroid Cancer Diagnostics Market Research Segmentation:

The thyroid cancer diagnostics market encompasses a diverse range of products, techniques, applications, and end-user segments, addressing different types of thyroid malignancies and patient needs.

By Type
  • Papillary Carcinoma
  • Follicular Carcinoma
By Technique
  • Imaging
  • Biopsy
  • Blood Test
By End-use
  • Hospital Laboratories
  • Cancer Diagnostic Centers
  • Research Institutes
By Region
  • North America
  • Europe
  • Asia Pacific
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa


Please Note: It will take 5 business days to complete the report upon order confirmation.

Table of Contents

187 Pages
1. Executive Summary
1.1. Thyroid Cancer Diagnostics Market Snapshot, 2025-2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Pipeline Analysis
3.3. Product Adoption Analysis
3.4. Value Chain Analysis
3.5. Key Promotional Strategies by Manufacturers
3.6. PESTLE Analysis
3.7. Porter’s Five Force Analysis
4. Thyroid Cancer Diagnostics Market Outlook:
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
4.3. Global Thyroid Cancer Diagnostics Market Outlook: Form
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Type, 2019-2024
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
4.3.3.1. Papillary Carcinoma
4.3.3.2. Follicular Carcinoma
4.3.4. Market Attractiveness Analysis: Type
4.4. Global Thyroid Cancer Diagnostics Market Outlook: Technique
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, Technique, 2019-2024
4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
4.4.3.1. Imaging
4.4.3.2. Biopsy
4.4.3.3. Blood Test
4.4.4. Market Attractiveness Analysis: Technique
4.5. Global Thyroid Cancer Diagnostics Market Outlook: Nature
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By End-use, 2019-2024
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
4.5.3.1. Hospital Laboratories
4.5.3.2. Cancer Diagnostic Centers
4.5.3.3. Research Institutes
4.5.4. Market Attractiveness Analysis: End-use
5. Global Thyroid Cancer Diagnostics Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Thyroid Cancer Diagnostics Market Outlook:
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
6.2.1. By Type
6.2.2. By Technique
6.2.3. By End-use
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
6.4.1. Papillary Carcinoma
6.4.2. Follicular Carcinoma
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
6.5.1. Imaging
6.5.2. Biopsy
6.5.3. Blood Test
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
6.6.1. Hospital Laboratories
6.6.2. Cancer Diagnostic Centers
6.6.3. Research Institutes
6.7. Market Attractiveness Analysis
7. Europe Thyroid Cancer Diagnostics Market Outlook:
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Type
7.2.3. By Technique
7.2.4. By End-use
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Turkey
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
7.4.1. Papillary Carcinoma
7.4.2. Follicular Carcinoma
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
7.5.1. Imaging
7.5.2. Biopsy
7.5.3. Blood Test
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
7.6.1. Hospital Laboratories
7.6.2. Cancer Diagnostic Centers
7.6.3. Research Institutes
7.7. Market Attractiveness Analysis
8. East Asia Thyroid Cancer Diagnostics Market Outlook:
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Type
8.2.3. By Technique
8.2.4. By End-use
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
8.4.1. Papillary Carcinoma
8.4.2. Follicular Carcinoma
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
8.5.1. Imaging
8.5.2. Biopsy
8.5.3. Blood Test
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Nature, 2025-2032
8.6.1. Hospital Laboratories
8.6.2. Cancer Diagnostic Centers
8.6.3. Research Institutes
8.7. Market Attractiveness Analysis
9. South Asia & Oceania Thyroid Cancer Diagnostics Market Outlook:
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Type
9.2.3. By Technique
9.2.4. By End-use
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
9.4.1. Papillary Carcinoma
9.4.2. Follicular Carcinoma
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
9.5.1. Imaging
9.5.2. Biopsy
9.5.3. Blood Test
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
9.6.1. Hospital Laboratories
9.6.2. Cancer Diagnostic Centers
9.6.3. Research Institutes
9.7. Market Attractiveness Analysis
10. Latin America Thyroid Cancer Diagnostics Market Outlook:
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Type
10.2.3. By Technique
10.2.4. By End-use
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
10.4.1. Papillary Carcinoma
10.4.2. Follicular Carcinoma
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
10.5.1. Imaging
10.5.2. Biopsy
10.5.3. Blood Test
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
10.6.1. Hospital Laboratories
10.6.2. Cancer Diagnostic Centers
10.6.3. Research Institutes
10.7. Market Attractiveness Analysis
11. Middle East & Africa Thyroid Cancer Diagnostics Market Outlook:
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Type
11.2.3. By Technique
11.2.4. By End-use
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
11.4.1. Papillary Carcinoma
11.4.2. Follicular Carcinoma
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technique, 2025-2032
11.5.1. Imaging
11.5.2. Biopsy
11.5.3. Blood Test
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
11.6.1. Hospital Laboratories
11.6.2. Cancer Diagnostic Centers
11.6.3. Research Institutes
11.7. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2025
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Abbott
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. F.Hoffmann-La Roche Ltd.
12.3.3. Thermo Fisher Scientific, Inc.
12.3.4. Siemens Healthcare GmbH
12.3.5. Bio-Rad Laboratories, Inc
12.3.6. GE HealthCare
12.3.7. Hologic, Inc
12.3.8. Koninklijke Philips N.V.
12.3.9. Toshiba Corporation
12.3.10. Agilent Technologies, Inc.
12.3.11. Illumina, Inc
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us